Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 524

1.

Selective decontamination of the digestive tract (SDD) in critically ill patients: a narrative review.

Wittekamp BHJ, Oostdijk EAN, Cuthbertson BH, Brun-Buisson C, Bonten MJM.

Intensive Care Med. 2019 Dec 9. doi: 10.1007/s00134-019-05883-9. [Epub ahead of print] Review.

PMID:
31820032
2.

Faecal carriage, risk factors, acquisition and persistence of ESBL-producing Enterobacteriaceae in dogs and cats and co-carriage with humans belonging to the same household.

van den Bunt G, Fluit AC, Spaninks MP, Timmerman AJ, Geurts Y, Kant A, Scharringa J, Mevius D, Wagenaar JA, Bonten MJM, van Pelt W, Hordijk J.

J Antimicrob Chemother. 2019 Nov 11. pii: dkz462. doi: 10.1093/jac/dkz462. [Epub ahead of print]

PMID:
31711228
3.

The added value of the selective SuperPolymyxin™ medium in detecting rectal carriage of Gram-negative bacteria with acquired colistin resistance in intensive care unit patients receiving selective digestive decontamination.

van Hout D, Janssen AB, Rentenaar RJ, Vlooswijk JPM, Boel CHE, Bonten MJM.

Eur J Clin Microbiol Infect Dis. 2019 Nov 6. doi: 10.1007/s10096-019-03718-5. [Epub ahead of print]

PMID:
31691864
4.

Dynamics of intestinal carriage of Extended-spectrum Beta-lactamase producing Enterobacteriaceae in the Dutch general population (2014-2016).

van den Bunt G, Fluit AC, Bootsma MCJ, Duijkeren EV, Scharringa J, Pelt WV, Bonten MJM.

Clin Infect Dis. 2019 Nov 5. pii: ciz1091. doi: 10.1093/cid/ciz1091. [Epub ahead of print]

PMID:
31688916
5.

Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host response.

Schouten LRA, Bos LDJ, Serpa Neto A, van Vught LA, Wiewel MA, Hoogendijk AJ, Bonten MJM, Cremer OL, Horn J, van der Poll T, Schultz MJ, Wösten-van Asperen RM; MARS consortium.

Intensive Care Med Exp. 2019 Oct 29;7(1):58. doi: 10.1186/s40635-019-0270-1.

6.

Prevalence, risk factors and genetic characterisation of extended-spectrum beta-lactamase and carbapenemase-producing Enterobacteriaceae (ESBL-E and CPE): a community-based cross-sectional study, the Netherlands, 2014 to 2016.

van den Bunt G, van Pelt W, Hidalgo L, Scharringa J, de Greeff SC, Schürch AC, Mughini-Gras L, Bonten MJM, Fluit AC.

Euro Surveill. 2019 Oct;24(41). doi: 10.2807/1560-7917.ES.2019.24.41.1800594.

7.

Sequence-based epidemiology of an OXA-48 plasmid during a hospital outbreak.

Hidalgo L, de Been M, Rogers MRC, Schürch AC, Scharringa J, van der Zee A, Bonten MJM, Fluit AC.

Antimicrob Agents Chemother. 2019 Oct 7. pii: AAC.01204-19. doi: 10.1128/AAC.01204-19. [Epub ahead of print]

PMID:
31591122
8.

Confounding by indication of the safety of de-escalation in community-acquired pneumonia: A simulation study embedded in a prospective cohort.

van Heijl I, Schweitzer VA, Boel CHE, Oosterheert JJ, Huijts SM, Dorigo-Zetsma W, van der Linden PD, Bonten MJM, van Werkhoven CH.

PLoS One. 2019 Sep 27;14(9):e0218062. doi: 10.1371/journal.pone.0218062. eCollection 2019.

9.

Effectiveness of extended- versus normal-release nitrofurantoin for cystitis: an instrumental variable analysis.

Ten Doesschate T, Groenwold RHH, Bonten MJM, van Werkhoven CH.

J Antimicrob Chemother. 2019 Nov 1;74(11):3337-3343. doi: 10.1093/jac/dkz350.

10.

Cost-effectiveness of selective digestive decontamination (SDD) versus selective oropharyngeal decontamination (SOD) in intensive care units with low levels of antimicrobial resistance: an individual patient data meta-analysis.

van Hout D, Plantinga NL, Bruijning-Verhagen PC, Oostdijk EAN, de Smet AMGA, de Wit GA de, Bonten MJM, van Werkhoven CH.

BMJ Open. 2019 Sep 6;9(9):e028876. doi: 10.1136/bmjopen-2018-028876.

11.

Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group.

Schweitzer VA, van Werkhoven CH, Rodríguez Baño J, Bielicki J, Harbarth S, Hulscher M, Huttner B, Islam J, Little P, Pulcini C, Savoldi A, Tacconelli E, Timsit JF, van Smeden M, Wolkewitz M, Bonten MJM, Walker AS, Llewelyn MJ; Joint Programming Initiative on Antimicrobial Resistance (JPIAMR) Working Group on Design of Antimicrobial Stewardship Evaluations.

Clin Microbiol Infect. 2019 Sep 4. pii: S1198-743X(19)30477-X. doi: 10.1016/j.cmi.2019.08.017. [Epub ahead of print]

12.

Robustness of sepsis-3 criteria in critically ill patients.

Verboom DM, Frencken JF, Ong DSY, Horn J, van der Poll T, Bonten MJM, Cremer OL, Klein Klouwenberg PMC.

J Intensive Care. 2019 Aug 29;7:46. doi: 10.1186/s40560-019-0400-6. eCollection 2019.

13.

Contact precautions in single-bed or multiple-bed rooms for patients with extended-spectrum β-lactamase-producing Enterobacteriaceae in Dutch hospitals: a cluster-randomised, crossover, non-inferiority study.

Kluytmans-van den Bergh MFQ, Bruijning-Verhagen PCJ, Vandenbroucke-Grauls CMJE, de Brauwer EIGB, Buiting AGM, Diederen BM, van Elzakker EPM, Friedrich AW, Hopman J, Al Naiemi N, Rossen JWA, Ruijs GJHM, Savelkoul PHM, Verhulst C, Vos MC, Voss A, Bonten MJM, Kluytmans JAJW; SoM Study Group.

Lancet Infect Dis. 2019 Oct;19(10):1069-1079. doi: 10.1016/S1473-3099(19)30262-2. Epub 2019 Aug 23.

PMID:
31451419
14.

Attributable sources of community-acquired carriage of Escherichia coli containing β-lactam antibiotic resistance genes: a population-based modelling study.

Mughini-Gras L, Dorado-García A, van Duijkeren E, van den Bunt G, Dierikx CM, Bonten MJM, Bootsma MCJ, Schmitt H, Hald T, Evers EG, de Koeijer A, van Pelt W, Franz E, Mevius DJ, Heederik DJJ; ESBL Attribution Consortium.

Lancet Planet Health. 2019 Aug;3(8):e357-e369. doi: 10.1016/S2542-5196(19)30130-5. Erratum in: Lancet Planet Health. 2019 Oct;3(10):e408.

15.

The effects of topical antibiotics on eradication and acquisition of third-generation cephalosporin and carbapenem-resistant Gram-negative bacteria in ICU patients; a post hoc analysis from a multicentre cluster-randomized trial.

Plantinga NL, Wittekamp BHJ, Brun-Buisson C, Bonten MJM; R-GNOSIS ICU study group.

Clin Microbiol Infect. 2019 Aug 14. pii: S1198-743X(19)30440-9. doi: 10.1016/j.cmi.2019.08.001. [Epub ahead of print]

PMID:
31421272
16.

A pilot study of a novel molecular host response assay to diagnose infection in patients after high-risk gastro-intestinal surgery.

Verboom DM, Koster-Brouwer ME, Ruurda JP, van Hillegersberg R, van Berge Henegouwen MI, Gisbertz SS, Scicluna BP, Bonten MJM, Cremer OL; MARS consortium.

J Crit Care. 2019 Dec;54:83-87. doi: 10.1016/j.jcrc.2019.07.020. Epub 2019 Jul 30.

17.

Roux-Y Gastric Bypass and Sleeve Gastrectomy directly change gut microbiota composition independent of surgery type.

Paganelli FL, Luyer M, Hazelbag CM, Uh HW, Rogers MRC, Adriaans D, Berbers RM, Hendrickx APA, Viveen MC, Groot JA, Bonten MJM, Fluit AC, Willems RJL, Leavis HL.

Sci Rep. 2019 Jul 29;9(1):10979. doi: 10.1038/s41598-019-47332-z.

18.

Plasma cytokine profile on admission related to aetiology in community-acquired pneumonia.

Burgmeijer EH, Duijkers R, Lutter R, Bonten MJM, Schweitzer VA, Boersma WG.

Clin Respir J. 2019 Oct;13(10):605-613. doi: 10.1111/crj.13062. Epub 2019 Aug 16.

PMID:
31310442
19.

Moderate positive predictive value of a multiplex real-time PCR on whole blood for pathogen detection in critically ill patients with sepsis.

van de Groep K, Bos MP, Varkila MRJ, Savelkoul PHM, Ong DSY, Derde LPG, Juffermans NP, van der Poll T, Bonten MJM, Cremer OL; MARS consortium.

Eur J Clin Microbiol Infect Dis. 2019 Oct;38(10):1829-1836. doi: 10.1007/s10096-019-03616-w. Epub 2019 Jun 26.

20.

Matrix metalloproteinase-8: a useful biomarker to refine the diagnosis of community-acquired pneumonia upon intensive care unit admission?

Uhel F, Scicluna BP, van Vught LA, Cremer OL, Bonten MJ, Schultz MJ, van der Poll T.

Crit Care. 2019 Jun 20;23(1):226. doi: 10.1186/s13054-019-2513-7. No abstract available.

21.

A post-hoc analysis of serotype-specific vaccine efficacy of 13-valent pneumococcal conjugate vaccine against clinical community acquired pneumonia from a randomized clinical trial in the Netherlands.

Gessner BD, Jiang Q, Van Werkhoven CH, Sings HL, Webber C, Scott D, Gruber WC, Grobbee DE, Bonten MJM, Jodar L.

Vaccine. 2019 Jul 9;37(30):4147-4154. doi: 10.1016/j.vaccine.2019.05.065. Epub 2019 May 31.

22.

Epidemiology and outcomes of source control procedures in critically ill patients with intra-abdominal infection.

van de Groep K, Verhoeff TL, Verboom DM, Bos LD, Schultz MJ, Bonten MJM, Cremer OL; MARS consortium.

J Crit Care. 2019 Aug;52:258-264. doi: 10.1016/j.jcrc.2019.02.029. Epub 2019 May 1.

PMID:
31054787
23.

Detection of Invasive Aspergillosis in Critically Ill Patients with Influenza: The Role of Plasma Galactomannan.

van de Groep K, Verboom DM, van de Veerdonk FL, Haas PA, van der Poll T, Schultz MJ, Bonten MJM, Cremer OL.

Am J Respir Crit Care Med. 2019 Sep 1;200(5):636-638. doi: 10.1164/rccm.201903-0587LE. No abstract available.

PMID:
31042411
24.

Decontamination Strategies for Critically Ill Patients-Reply.

Wittekamp BH, Plantinga NL, Bonten MJM.

JAMA. 2019 Apr 9;321(14):1410. doi: 10.1001/jama.2019.0456. No abstract available.

PMID:
30964524
25.

A diagnostic algorithm for the surveillance of deep surgical site infections after colorectal surgery.

Mulder T, Kluytmans-van den Bergh MFQ, van Mourik MSM, Romme J, Crolla RMPH, Bonten MJM, Kluytmans JAJW.

Infect Control Hosp Epidemiol. 2019 May;40(5):574-578. doi: 10.1017/ice.2019.36. Epub 2019 Mar 14.

26.

Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital.

Díaz-Agero Pérez C, López-Fresneña N, Rincon Carlavilla AL, Hernandez Garcia M, Ruiz-Garbajosa P, Aranaz-Andrés JM, Maechler F, Gastmeier P, Bonten MJM, Canton R.

BMJ Open. 2019 Mar 1;9(3):e024879. doi: 10.1136/bmjopen-2018-024879.

27.

[New antibiotics: an overview].

Lemkes BA, Richel O, Bonten MJ, van der Linden PD, Wiersinga WJ.

Ned Tijdschr Geneeskd. 2019 Feb 13;163. pii: D3107. Dutch.

PMID:
30816653
28.

Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment Efficacy in Future Hospital-acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials.

Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF.

Clin Infect Dis. 2019 Nov 13;69(11):1912-1918. doi: 10.1093/cid/ciz093.

PMID:
30722013
29.

Profile of the SeptiCyte™ LAB gene expression assay to diagnose infection in critically ill patients.

Verboom DM, Koster-Brouwer ME, Varkila MRJ, Bonten MJM, Cremer OL.

Expert Rev Mol Diagn. 2019 Feb;19(2):95-108. doi: 10.1080/14737159.2019.1567333. Epub 2019 Feb 5. Review.

PMID:
30623693
30.

Cardiac events after macrolides or fluoroquinolones in patients hospitalized for community-acquired pneumonia: post-hoc analysis of a cluster-randomized trial.

Postma DF, Spitoni C, van Werkhoven CH, van Elden LJR, Oosterheert JJ, Bonten MJM.

BMC Infect Dis. 2019 Jan 7;19(1):17. doi: 10.1186/s12879-018-3630-7.

31.

Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.

van de Groep K, Nierkens S, Cremer OL, Peelen LM, Klein Klouwenberg PMC, Schultz MJ, Hack CE, van der Poll T, Bonten MJM, Ong DSY; MARS consortium.

Crit Care. 2018 Dec 18;22(1):348. doi: 10.1186/s13054-018-2261-0.

32.

Myocardial Injury in Critically Ill Patients with Community-acquired Pneumonia. A Cohort Study.

Frencken JF, van Baal L, Kappen TH, Donker DW, Horn J, van der Poll T, van Klei WA, Bonten MJM, Cremer OL; Members of the MARS Consortium.

Ann Am Thorac Soc. 2019 May;16(5):606-612. doi: 10.1513/AnnalsATS.201804-286OC.

PMID:
30521759
33.

Oral fosfomycin versus ciprofloxacin in women with E.coli febrile urinary tract infection, a double-blind placebo-controlled randomized controlled non-inferiority trial (FORECAST).

Ten Doesschate T, van Mens SP, van Nieuwkoop C, Geerlings SE, Hoepelman AIM, Bonten MJM.

BMC Infect Dis. 2018 Dec 5;18(1):626. doi: 10.1186/s12879-018-3562-2.

34.

The quality of studies evaluating antimicrobial stewardship interventions: a systematic review.

Schweitzer VA, van Heijl I, van Werkhoven CH, Islam J, Hendriks-Spoor KD, Bielicki J, Bonten MJM, Walker AS, Llewelyn MJ; Consensus on Antimicrobial Stewardship Evaluations (CASE) study group.

Clin Microbiol Infect. 2019 May;25(5):555-561. doi: 10.1016/j.cmi.2018.11.002. Epub 2018 Nov 23.

PMID:
30472426
35.

Relevance of healthcare-associated pneumonia for empirical antibiotic therapy in the Netherlands.

Schweitzer VA, van Werkhoven CH, van Heijl I, Smits RF, Boel CHE, Bonten MJM, Postma DF, Oosterheert JJ.

Neth J Med. 2018 Nov;76(9):389-396.

36.

Adaptive designs in clinical trials in critically ill patients: principles, advantages and pitfalls.

van Werkhoven CH, Harbarth S, Bonten MJM.

Intensive Care Med. 2019 May;45(5):678-682. doi: 10.1007/s00134-018-5426-z. Epub 2018 Oct 30. No abstract available.

37.

Decontamination Strategies and Bloodstream Infections With Antibiotic-Resistant Microorganisms in Ventilated Patients: A Randomized Clinical Trial.

Wittekamp BH, Plantinga NL, Cooper BS, Lopez-Contreras J, Coll P, Mancebo J, Wise MP, Morgan MPG, Depuydt P, Boelens J, Dugernier T, Verbelen V, Jorens PG, Verbrugghe W, Malhotra-Kumar S, Damas P, Meex C, Leleu K, van den Abeele AM, Gomes Pimenta de Matos AF, Fernández Méndez S, Vergara Gomez A, Tomic V, Sifrer F, Villarreal Tello E, Ruiz Ramos J, Aragao I, Santos C, Sperning RHM, Coppadoro P, Nardi G, Brun-Buisson C, Bonten MJM.

JAMA. 2018 Nov 27;320(20):2087-2098. doi: 10.1001/jama.2018.13765.

38.

[A trial to study the effect of influenza vaccination in the elderly: ethical, feasible and badly needed].

Ekkelenkamp MB, van Werkhoven CH, Bruijning-Verhagen PCJ, Bonten MJM.

Ned Tijdschr Geneeskd. 2018 Sep 6;162. pii: D3285. Dutch.

PMID:
30306759
39.

Antibiotic treatment of gastroenteritis in primary care.

Schierenberg A, Bruijning-Verhagen PCJ, van Delft S, Bonten MJM, de Wit NJ.

J Antimicrob Chemother. 2019 Jan 1;74(1):207-213. doi: 10.1093/jac/dky385.

PMID:
30285243
40.

Carriage of antibiotic-resistant Gram-negative bacteria after discontinuation of selective decontamination of the digestive tract (SDD) or selective oropharyngeal decontamination (SOD).

de Jonge E, de Wilde RBP, Juffermans NP, Oostdijk EAN, Bernards AT, van Essen EHR, Kuijper EJ, Visser CE, Kesecioglu J, Bonten MJM.

Crit Care. 2018 Sep 29;22(1):243. doi: 10.1186/s13054-018-2170-2.

41.

'Development of diagnostic prediction tools for bacteraemia caused by 3rd generation cephalosporin-resistant Enterobacteriaceae in suspected bacterial infections' - Author's reply.

Rottier WC, Deelen JWT, van Werkhoven CH, Bonten MJM.

Clin Microbiol Infect. 2018 Dec;24(12):1349-1350. doi: 10.1016/j.cmi.2018.09.003. Epub 2018 Sep 26. No abstract available.

42.

The authors reply.

Koster-Brouwer ME, Verboom DM, Bonten MJM, Cremer OL.

Crit Care Med. 2018 Aug;46(8):e820-e821. doi: 10.1097/CCM.0000000000003246. No abstract available.

PMID:
30004982
43.

Fosfomycin Etest for Enterobacteriaceae: Interobserver and interlaboratory agreement.

van Mens SP, Ten Doesschate T, Kluytmans-van den Bergh MFQ, Mouton JW, Rossen JWA, Verhulst C, Bonten MJM, Kluytmans JAJW.

Int J Antimicrob Agents. 2018 Nov;52(5):678-681. doi: 10.1016/j.ijantimicag.2018.06.014. Epub 2018 Jun 27.

PMID:
29958976
44.

A public health evaluation of 13-valent pneumococcal conjugate vaccine impact on adult disease outcomes from a randomized clinical trial in the Netherlands.

Gessner BD, Jiang Q, Van Werkhoven CH, Sings HL, Webber C, Scott D, Neuzil KM, O'Brien KL, Wunderink RG, Grobbee DE, Bonten MJM, Jodar L.

Vaccine. 2019 Sep 10;37(38):5777-5787. doi: 10.1016/j.vaccine.2018.05.097. Epub 2018 May 31.

45.

Dynamics of colistin and tobramycin resistance among Enterobacter cloacae during prolonged use of selective decontamination of the digestive tract.

Dautzenberg MJD, Bayjanov JR, Leverstein-van Hall MA, Muller AE, Gelinck LBS, Jansen CL, Leyten EMS, Ruys T, Scharringa J, van der Starre RE, Fluit AC, Bonten MJM.

Antimicrob Resist Infect Control. 2018 May 22;7:67. doi: 10.1186/s13756-018-0356-7. eCollection 2018.

46.

Limited influence of hospital wastewater on the microbiome and resistome of wastewater in a community sewerage system.

Buelow E, Bayjanov JR, Majoor E, Willems RJ, Bonten MJ, Schmitt H, van Schaik W.

FEMS Microbiol Ecol. 2018 Jul 1;94(7). doi: 10.1093/femsec/fiy087.

PMID:
29767712
47.

Development and first evaluation of a novel multiplex real-time PCR on whole blood samples for rapid pathogen identification in critically ill patients with sepsis.

van de Groep K, Bos MP, Savelkoul PHM, Rubenjan A, Gazenbeek C, Melchers WJG, van der Poll T, Juffermans NP, Ong DSY, Bonten MJM, Cremer OL; MARS consortium.

Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1333-1344. doi: 10.1007/s10096-018-3255-1. Epub 2018 Apr 26.

48.

Exposure to Coxiella burnetii and risk of non-Hodgkin lymphoma: a retrospective population-based analysis in the Netherlands.

van Roeden SE, van Houwelingen F, Donkers CMJ, Hogewoning SJ, de Lange MMA, van der Hoek W, Kampschreur LM, Bonten MJM, Hoepelman AIM, Bleeker-Rovers CP, Wever PC, Oosterheert JJ.

Lancet Haematol. 2018 May;5(5):e211-e219. doi: 10.1016/S2352-3026(18)30038-3. Epub 2018 Apr 9.

PMID:
29650493
49.

Development of diagnostic prediction tools for bacteraemia caused by third-generation cephalosporin-resistant enterobacteria in suspected bacterial infections: a nested case-control study.

Rottier WC, van Werkhoven CH, Bamberg YRP, Dorigo-Zetsma JW, van de Garde EM, van Hees BC, Kluytmans JAJW, Kuck EM, van der Linden PD, Prins JM, Thijsen SFT, Verbon A, Vlaminckx BJM, Ammerlaan HSM, Bonten MJM.

Clin Microbiol Infect. 2018 Dec;24(12):1315-1321. doi: 10.1016/j.cmi.2018.03.023. Epub 2018 Mar 23.

50.

Risk prediction for Staphylococcus aureus surgical site infection following cardiothoracic surgery; A secondary analysis of the V710-P003 trial.

Paling FP, Olsen K, Ohneberg K, Wolkewitz M, Fowler VG Jr, DiNubile MJ, Jafri HS, Sifakis F, Bonten MJM, Harbarth SJ, Kluytmans JAJW.

PLoS One. 2018 Mar 21;13(3):e0193445. doi: 10.1371/journal.pone.0193445. eCollection 2018.

Supplemental Content

Loading ...
Support Center